Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

This Small-Cap Healthcare Stock Is Up 300% in a Year and Is Quickly Gaining a Following

  • NeurAxis (NRXS) specializes in neuromodulation therapies, targeting chronic abdominal pain in pediatric and adult patients.
  • NRXS exhibits exceptional technical momentum with shares trading at new all-time highs.
  • The stock is up more than 300% over the past 52 weeks and maintains a 100% “Buy” opinion from Barchart.  
  • Healthcare sector tailwinds support NRXS, yet prudent risk management is advised given volatility and speculative characteristics.

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.